|Working Paper 132||“All offices” experience of term assurances, 2015-2018 (Issue date: 07/05/2020)|
|Working Paper 125||Additional analysis of the experience of term assurances, 2011-2016 (Issue date: 15/11/2019)|
|Working Paper 123||
"All offices” experience of term assurances, 2011-2016 (v01: issue date: 18/07/2019; v02 issue date: 07/05/2020)
|Working Paper 110||Working Paper 110: Using the CMI Mortality Projections Model for assured lives (Issue date: 04/10/2018; Response date: 31/12/2018)|
|Working Paper 108||Interim “all offices” experience of term assurances, 2011-2015 (v01 issue date: 08/06/2018; v02 issue date: 07/05/2020; Response date: 12/07/2018)|
|Working Paper 94||Final "08" Series accelerated critical illness and term mortality tables (Issue date: 27/01/2017)|
|Working Paper 92||Proposed "08" Series term mortality tables (Issue Date: 07/10/2016; Response date: 30/11/2016)|
|Proposed "08" Series accelerated critical illness tables (Issue date: 06/05/2016; Reissued: 07/10/2016; Response date: 30/11/2016)|
|All-Offices Mortality and Critical Illness Experience for the 2007-2010 Quadrennium (Issue date: 03/12/2014; Reissued: 01/02/2016)|
|A revised approach for analysing CMI critical illness experience and restated results for accelerated business, 2003-2006 (Issue date: 10/05/2013)|
|Supplementary analyses to CMI critical illness diagnosis rates for accelerated business, 2003-2006|
|Cause-specific CMI critical illness diagnosis rates for accelerated business, 2003-2006 (Issue date: 15/06/2011)|
|CMI critical illness diagnosis rates for accelerated business 2003-2006 (Issue date: 24/01/2011)|
|CMI critical illness diagnosis rates for accelerated business 1999-2004 (Issue date: 12/02/2010)|
|The mortality of impaired assured lives: Report on 1995-2006 experience and consultation on the future of the investigation (Issue date: 14/01/2009)|
|A new methodology for analysing CMI critical illness experience (Issue date: 23/07/2008)|
|Progress towards an improved methodology for analysing CMI critical illness experience (Issue date: 27/07/2007)|
|1999-2002 critical illness experience: feedback on Working paper 14 and future work (Issue date: 01/12/2005)|
|Methodology underlying the 1999-2002 CMI critical illness experience investigation (Issue date: 05/05/2005)|
|The graduation of the CMI 1999-2002 mortality experience: feedback on Working paper 8 and proposed assured lives graduations (Issue date: 11/04/2005)|
If you have any questions about the CMI please email
Filter or search events
As part of the ARC Webinar Series 2021, this webinar will review the work of the UEA/Aviva research team over the last four years on a major research programme funded by the IFoA’s Actuarial Research Centre.
Climate change poses a significant threat across many regions and sectors, and businesses. Insurers and asset managers, must play a role in ensuring transparency around climate related risks and opportunities.
Whilst insurers have been performing stress and scenario testing for many years, in the last 12 months the PRA has increased its focus on the ability to identify, measure and increase financial and operational resilience.
There is widening debate that many of our social, financial and regulatory institutions need to be rethought so that we can create more sustainable futures, particularly in light of the Covid-19 pandemic, the policy/macro-economic response to the pandemic and how it affects consumers, as well as the impending climate crisis. This multi-day series of three keynote webinars, individually presented by leading economist John Kay, Sir Paul Collier, Professor of Economics and Public Policy at the Blavatnik School of Government, Ashok Gupta, Chair at Mercer Ltd, and Nico Aspinall, Chief Investment Officer at B&CE, will open up discussion on these essential topics. The series will culminate in a panel session with Chief Economist of the Bank of England, Andy Haldane.
This webinar provides an overview of the state of the UK protection market, and how different insurers are using different levels of sophistication to price (such as using customer demand models). It considers how insurers have implemented these sophisticated pricing techniques, and the practical challenges they have faced.
This discussion will revolve around the latest industry developments including and introduction to Part VII transfers and Schemes of Arrangement (process, parties involved and recent events), insights and lessons from recent with-profits transactions and restructurings (including Equitable Life and Pru-Rothesay), how firms can apply these learnings to future arrangements, and the outlook for future with-profits transactions and restructurings (including the impacts of Covid-19 and Brexit)
What is stewardship and how has the landscape changed under the 2020 UK Stewardship Code? How does effective stewardship create long term value for beneficiaries and what roles do asset owners and asset managers play in active stewardship. This webinar will offer answers to these questions in a practical approach to stewardship reporting.
Dr Catherine Donnelly will present the basics of the structures for pooling longevity risks and summarise recent research results in this area in addition to outlinging future research around this topic. This is work under a research programme funded by the IFoA's Actuarial Research Centre, called 'Minimizing longevity and investment risk while optimising future pension plans'.
Mis-estimation risk is a key element of demographic risk, and past work has focused on mis-estimation risk on a run-off basis. However, this does not meet the requirements of regulatory regimes like Solvency II, which demands that capital requirements are set through the prism of a finite horizon like one year. This paper presents a value-at-risk approach to mis-estimation risk suitable for Solvency II work.